Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

Clinical trial NCT03786692 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03786692
Sponsor: Fox Chase Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Carcinoma of Lung, TNM Stage 4

Start date: 2019-09-04
Primary completion: 2026-12-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.